{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:24:54Z","timestamp":1792070694136,"version":"4.4.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK081662"],"award-info":[{"award-number":["DK081662"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK096994"],"award-info":[{"award-number":["DK096994"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.steroids.2014.08.016","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T12:45:57Z","timestamp":1409921157000},"page":"54-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["Effects of aldosterone on insulin sensitivity and secretion"],"prefix":"10.1016","volume":"91","author":[{"given":"James M.","family":"Luther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.08.016_b0005","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196511182732106","article-title":"Hypertension, the potassium ion and impaired carbohydrate tolerance","volume":"273","author":"Conn","year":"1965","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.08.016_b0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","article-title":"Clinical characteristics of primary aldosteronism from an analysis of 145 cases","volume":"107","author":"Conn","year":"1964","journal-title":"Am J Surg"},{"key":"10.1016\/j.steroids.2014.08.016_b0015","doi-asserted-by":"crossref","unstructured":"American Diabetes A: Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36 Suppl 1:S67\u201374.","DOI":"10.2337\/dc13-S067"},{"key":"10.1016\/j.steroids.2014.08.016_b0020","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/en.2013-1115","article-title":"Antioxidant N-acetylcysteine protects pancreatic beta-cells against aldosterone-induced oxidative stress and apoptosis in female db\/db mice and insulin-producing MIN6 cells","volume":"154","author":"Jin","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.08.016_b0025","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1007\/s00125-011-2158-9","article-title":"Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets","volume":"54","author":"Luther","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.08.016_b0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00456122","article-title":"Effect of adrenal steroids on insulin release from cultured rat islets of Langerhans","volume":"29","author":"Pierluissi","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.08.016_b0035","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.steroids.2014.08.016_b0040","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJM198104163041602","article-title":"The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients","volume":"304","author":"Tuck","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.08.016_b0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0952-3278(99)80020-9","article-title":"Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans","volume":"60","author":"Goodfriend","year":"1999","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.steroids.2014.08.016_b0050","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1210\/jc.2007-1088","article-title":"Body mass index predicts aldosterone production in normotensive adults on a high-salt diet","volume":"92","author":"Bentley-Lewis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0055","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Ehrhart-Bornstein","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.steroids.2014.08.016_b0060","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.HYP.0000113294.06704.64","article-title":"Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.08.016_b0065","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1681\/ASN.2006080944","article-title":"Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors","volume":"17","author":"Nagase","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.steroids.2014.08.016_b0070","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMoa065061","article-title":"Effect of ramipril on the incidence of diabetes","volume":"355","author":"Investigators","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.08.016_b0075","doi-asserted-by":"crossref","unstructured":"Group NS, McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso M, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamas G, Tognoni G, Tuomilehto J, Villamil AS, Vozar J, Califf RM: Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010;362:1477\u20131490.","DOI":"10.1056\/NEJMoa1001121"},{"key":"10.1016\/j.steroids.2014.08.016_b0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.08.016_b0085","doi-asserted-by":"crossref","unstructured":"DeFronzo RA: Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667\u2013687.","DOI":"10.2337\/diab.37.6.667"},{"key":"10.1016\/j.steroids.2014.08.016_b0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/eje.0.1500097","article-title":"Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies","volume":"150","author":"Ahren","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.steroids.2014.08.016_b0095","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diab.42.11.1663","article-title":"Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects","volume":"42","author":"Kahn","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/j.steroids.2014.08.016_b0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","article-title":"Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study","volume":"47","author":"Gastaldelli","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.08.016_b0105","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1172\/JCI110398","article-title":"Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose","volume":"68","author":"Bergman","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.08.016_b0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1104345","article-title":"Type 2 diabetes-a matter of beta-cell life and death?","volume":"307","author":"Rhodes","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.steroids.2014.08.016_b0115","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.steroids.2014.08.016_b0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCULATIONAHA.107.721878","article-title":"Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004","volume":"118","author":"Pande","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.08.016_b0125","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0735-1097(02)02051-X","article-title":"Relationship between obesity, insulin resistance, and coronary heart disease risk","volume":"40","author":"Abbasi","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.steroids.2014.08.016_b0130","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1161\/01.ATV.20.2.538","article-title":"Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study","volume":"20","author":"Pyorala","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.steroids.2014.08.016_b0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.08.016_b0140","doi-asserted-by":"crossref","unstructured":"Calhoun DA: Is there an unrecognized epidemic of primary aldosteronism? Pro. Hypertension 2007;50:447\u2013453; discussion 447\u2013453.","DOI":"10.1161\/HYPERTENSIONAHA.106.086116"},{"key":"10.1016\/j.steroids.2014.08.016_b0145","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/ajh.2010.44","article-title":"Associations of the \u2212344 T>C and the 3097 G>A polymorphisms of CYP11B2 gene with hypertension, type 2 diabetes, and metabolic syndrome in a French population","volume":"23","author":"Bellili","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0150","doi-asserted-by":"crossref","first-page":"13219","DOI":"10.1073\/pnas.221467098","article-title":"Genetic variation in aldosterone synthase predicts plasma glucose levels","volume":"98","author":"Ranade","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.steroids.2014.08.016_b0155","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.amjhyper.2006.07.012","article-title":"\u2212344C\/T Variant in the promoter of the aldosterone synthase gene (CYP11B2) is associated with metabolic syndrome in men","volume":"20","author":"Russo","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0160","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0895-7061(98)00048-X","article-title":"Genetic determination of plasma aldosterone levels in essential hypertension","volume":"11","author":"Pojoga","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.08.016_b0170","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diab Care"},{"key":"10.1016\/j.steroids.2014.08.016_b0175","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/hrt.2009.173344","article-title":"Aldosterone status associated with insulin resistance in patients with heart failure\u2013data from the ALOFT study","volume":"95","author":"Freel","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.steroids.2014.08.016_b0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/j.1550-8528.1999.tb00418.x","article-title":"Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women","volume":"7","author":"Goodfriend","year":"1999","journal-title":"Obes Res"},{"key":"10.1016\/j.steroids.2014.08.016_b0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jash.2011.09.005","article-title":"Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans","volume":"6","author":"Huan","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.0000253258.36141.c7","article-title":"Association of adrenal steroids with hypertension and the metabolic syndrome in blacks","volume":"49","author":"Kidambi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.08.016_b0195","doi-asserted-by":"crossref","unstructured":"Kidambi S, Kotchen JM, Krishnaswami S, Grim CE, Kotchen TA: Hypertension, insulin resistance, and aldosterone: sex-specific relationships. J Clin Hypertens (Greenwich) 2009;11:130\u2013137.","DOI":"10.1111\/j.1751-7176.2009.00084.x"},{"key":"10.1016\/j.steroids.2014.08.016_b0200","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc07-0525","article-title":"Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients","volume":"30","author":"Colussi","year":"2007","journal-title":"Diabet Care"},{"key":"10.1016\/j.steroids.2014.08.016_b0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/HJH.0b013e3280108e6f","article-title":"Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study","volume":"25","author":"Giacchetti","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0210","first-page":"21","article-title":"Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment","volume":"108","author":"Sindelka","year":"2000","journal-title":"Exp Clin Endocr Diab"},{"key":"10.1016\/j.steroids.2014.08.016_b0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.33549\/physiolres.930000.49.241","article-title":"Impaired insulin action in primary hyperaldosteronism","volume":"49","author":"Widimsky","year":"2000","journal-title":"Physiol Res"},{"key":"10.1016\/j.steroids.2014.08.016_b0220","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2265.1994.tb02573.x","article-title":"Increased insulin sensitivity in patients with aldosterone producing adenoma","volume":"41","author":"Ishimori","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.steroids.2014.08.016_b0230","doi-asserted-by":"crossref","first-page":"603","DOI":"10.33549\/physiolres.930123","article-title":"Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?","volume":"50","author":"Widimsky","year":"2001","journal-title":"Physiol Res"},{"key":"10.1016\/j.steroids.2014.08.016_b0235","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone excess impairs first phase insulin secretion in primary aldosteronism","volume":"98","author":"Fischer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0240","doi-asserted-by":"crossref","unstructured":"Kumagai E, Adachi H, Jacobs DR, Jr., Hirai Y, Enomoto M, Fukami A, Otsuka M, Kumagae S, Nanjo Y, Yoshikawa K, Esaki E, Yokoi K, Ogata K, Kasahara A, Tsukagawa E, Ohbu-Murayama K, Imaizumi T: Plasma aldosterone levels and development of insulin resistance: prospective study in a general population. Hypertension 2011;58:1043\u20131048.","DOI":"10.1161\/HYPERTENSIONAHA.111.180521"},{"key":"10.1016\/j.steroids.2014.08.016_b0245","doi-asserted-by":"crossref","first-page":"503","DOI":"10.33549\/physiolres.930298","article-title":"Does the treatment of primary hyperaldosteronism influence glucose tolerance?","volume":"52","author":"Strauch","year":"2003","journal-title":"Physiol Res"},{"key":"10.1016\/j.steroids.2014.08.016_b0250","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.steroids.2014.08.016_b0255","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00125-009-1313-z","article-title":"The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action","volume":"52","author":"Barrett","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.08.016_b0260","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrm3351","article-title":"Regulation of glucose transport by insulin: traffic control of GLUT4","volume":"13","author":"Leto","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.steroids.2014.08.016_b0265","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-biochem-060109-094246","article-title":"Regulation of glucose transporter translocation in health and diabetes","volume":"81","author":"Bogan","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.steroids.2014.08.016_b0270","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.cellsig.2011.05.022","article-title":"Rac1 signalling towards GLUT4\/glucose uptake in skeletal muscle","volume":"23","author":"Chiu","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.steroids.2014.08.016_b0275","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1172\/JCI67166","article-title":"Insulin resistance in the vasculature","volume":"123","author":"Mather","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.08.016_b0280","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1172\/JCI118124","article-title":"Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans","volume":"96","author":"Baron","year":"1995","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.1016\/j.steroids.2014.08.016_b0285","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.2337\/diab.45.1.S105","article-title":"The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide","volume":"45","author":"Baron","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.steroids.2014.08.016_b0290","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nm.2891","article-title":"Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors","volume":"18","author":"McCurley","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.steroids.2014.08.016_b0295","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/ATVBAHA.113.302854","article-title":"Aldosterone promotes vascular remodeling by direct effects on smooth muscle cell mineralocorticoid receptors","volume":"34","author":"Pruthi","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.steroids.2014.08.016_b0300","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/ki.2012.170","article-title":"Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury","volume":"82","author":"Luther","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.steroids.2014.08.016_b0305","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1097-0185(199610)246:2<208::AID-AR7>3.0.CO;2-X","article-title":"Capillary and muscle fiber type changes in DOCA-salt hypertensive rats","volume":"246","author":"Hernandez","year":"1996","journal-title":"Anat Rec"},{"key":"10.1016\/j.steroids.2014.08.016_b0310","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.mvr.2005.03.004","article-title":"Muscle arteriolar and venular reactivity in two models of hypertensive rats","volume":"69","author":"Losada","year":"2005","journal-title":"Microvasc Res"},{"key":"10.1016\/j.steroids.2014.08.016_b0315","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/HYPERTENSIONAHA.107.093955","article-title":"Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells","volume":"50","author":"Hitomi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.08.016_b0320","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/db12-0905","article-title":"Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?","volume":"62","author":"Bender","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.steroids.2014.08.016_b0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/ATVBAHA.111.240697","article-title":"Aldosterone induces vascular insulin resistance by increasing insulin-like growth factor-1 receptor and hybrid receptor","volume":"32","author":"Sherajee","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.steroids.2014.08.016_b0330","doi-asserted-by":"crossref","first-page":"5851","DOI":"10.1210\/en.2010-0350","article-title":"Aldosterone enhances IGF-I-mediated signaling and biological function in vascular smooth muscle cells","volume":"151","author":"Cascella","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.08.016_b0335","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/HYPERTENSIONAHA.113.01967","article-title":"Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness","volume":"63","author":"Galmiche","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.08.016_b0340","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/HYPERTENSIONAHA.113.01273","article-title":"Aldosterone and vascular mineralocorticoid receptors: regulators of ion channels beyond the kidney","volume":"63","author":"Dupont","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.08.016_b0345","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1152\/ajpendo.90563.2008","article-title":"Four grams of glucose","volume":"296","author":"Wasserman","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0350","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2337\/db12-1502","article-title":"Hyaluronan accumulates with high-fat feeding and contributes to insulin resistance","volume":"62","author":"Kang","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.steroids.2014.08.016_b0355","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.08.016_b0360","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cca.2009.06.030","article-title":"Impact of excess aldosterone on glucose homeostasis in adult male rat","volume":"407","author":"Selvaraj","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.steroids.2014.08.016_b0365","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-012-1452-2","article-title":"Excess aldosterone-induced changes in insulin signaling molecules and glucose oxidation in gastrocnemius muscle of adult male rat","volume":"372","author":"Selvaraj","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.steroids.2014.08.016_b0370","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2013.10.051","article-title":"Aldosterone aggravates glucose intolerance induced by high fructose","volume":"720","author":"Sherajee","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.steroids.2014.08.016_b0375","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","article-title":"Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat","volume":"295","author":"Lastra","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0380","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1172\/JCI105769","article-title":"An extrarenal mechanism of potassium adaptation","volume":"47","author":"Alexander","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.08.016_b0385","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1152\/ajplegacy.1970.218.3.616","article-title":"An extrarenal action of aldosterone on mammalian skeletal muscle","volume":"218","author":"Adler","year":"1970","journal-title":"Am J Physiol"},{"key":"10.1016\/j.steroids.2014.08.016_b0390","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/0003-4819-84-4-426","article-title":"Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms","volume":"84","author":"Goldfarb","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.steroids.2014.08.016_b0395","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1172\/JCI104981","article-title":"Effect of very small concentrations of insulin on forearm metabolism. Persistence of its action on potassium and free fatty acids without its effect on glucose","volume":"43","author":"Zierler","year":"1964","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.08.016_b0400","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1152\/ajplegacy.1960.198.5.1066","article-title":"Effect of insulin on potassium efflux from rat muscle in the presence and absence of glucose","volume":"198","author":"Zierler","year":"1960","journal-title":"Am J Physiol"},{"key":"10.1016\/j.steroids.2014.08.016_b0405","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1210\/en.2008-1018","article-title":"Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes","volume":"150","author":"Wada","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.08.016_b0410","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0031-1277226","article-title":"Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes","volume":"43","author":"Li","year":"2011","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.steroids.2014.08.016_b0415","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.steroids.2014.08.016_b0420","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.08.016_b0425","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","article-title":"Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines","volume":"117","author":"Guo","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.08.016_b0430","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/cvr\/cvp191","article-title":"Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice","volume":"84","author":"Hirata","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.steroids.2014.08.016_b0435","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mce.2012.02.007","article-title":"Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients","volume":"355","author":"Williams","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2014.08.016_b0440","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.amjhyper.2007.03.012","article-title":"Adiponectin and insulin sensitivity in primary aldosteronism","volume":"20","author":"Fallo","year":"2007","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0445","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2010-0097","article-title":"Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism","volume":"95","author":"Urbanet","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0450","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00125-012-2814-8","article-title":"Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice","volume":"56","author":"Luo","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.08.016_b0455","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1091\/mbc.E10-01-0042","article-title":"AS160 modulates aldosterone-stimulated epithelial sodium channel forward trafficking","volume":"21","author":"Liang","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.steroids.2014.08.016_b0460","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/BJ20070649","article-title":"Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF. PMA and AICAR.","volume":"407","author":"Geraghty","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.steroids.2014.08.016_b0465","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.tem.2011.07.005","article-title":"The capture of phosphoproteins by 14-3-3 proteins mediates actions of insulin","volume":"22","author":"Chen","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0470","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1440-1681.1987.tb00955.x","article-title":"High-affinity aldosterone binding in rat liver\u2013a re-evaluation","volume":"14","author":"Zaini","year":"1987","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.steroids.2014.08.016_b0475","doi-asserted-by":"crossref","unstructured":"Reul JM, Pearce PT, Funder JW, Krozowski ZS: Type I and type II corticosteroid receptor gene expression in the rat: effect of adrenalectomy and dexamethasone administration. Mol Endocrinol 1989;3:1674\u20131680.","DOI":"10.1210\/mend-3-10-1674"},{"key":"10.1016\/j.steroids.2014.08.016_b0480","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1507\/endocrj.51.243","article-title":"Aldosterone stimulates gene expression of hepatic gluconeogenic enzymes through the glucocorticoid receptor in a manner independent of the protein kinase B cascade","volume":"51","author":"Yamashita","year":"2004","journal-title":"Endocr J"},{"key":"10.1016\/j.steroids.2014.08.016_b0485","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bbrc.2006.02.065","article-title":"Mineralocorticoid receptor is involved in the regulation of genes responsible for hepatic glucose production","volume":"342","author":"Liu","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.steroids.2014.08.016_b0490","doi-asserted-by":"crossref","first-page":"E1415","DOI":"10.1152\/ajpendo.00419.2013","article-title":"Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet","volume":"305","author":"Wada","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0495","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.08.016_b0500","first-page":"407","article-title":"Selective aldosterone blocker ameliorates the progression of non-alcoholic steatohepatitis in rats","volume":"26","author":"Noguchi","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.steroids.2014.08.016_b0505","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/MEG.0b013e328360554a","article-title":"The effects of aldosterone on diet-induced fatty liver formation in male C57BL\/6 mice: comparison of adrenalectomy and mineralocorticoid receptor blocker","volume":"25","author":"Gamliel-Lazarovich","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.steroids.2014.08.016_b0510","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ajh.2009.206","article-title":"Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study","volume":"23","author":"Fallo","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0515","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1152\/ajpregu.91000.2008","article-title":"The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension","volume":"298","author":"Ndisang","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.steroids.2014.08.016_b0520","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/me.2007-0568","article-title":"Research resource: nuclear hormone receptor expression in the endocrine pancreas","volume":"22","author":"Chuang","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2014.08.016_b0525","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","article-title":"GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone","volume":"57","author":"Gros","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.08.016_b0530","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.steroids.2012.04.001","article-title":"Position paper: the membrane estrogen receptor GPER\u2013Clues and questions","volume":"77","author":"Barton","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.08.016_b0535","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/cvr\/cvs016","article-title":"AH JD: Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase","volume":"94","author":"Batenburg","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.steroids.2014.08.016_b0540","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1172\/JCI64151","article-title":"MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity","volume":"122","author":"Jacovetti","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.steroids.2014.08.016_b0545","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1210\/en.2013-1357","article-title":"GPER deficiency in male mice results in insulin resistance, dyslipidemia, and a proinflammatory state","volume":"154","author":"Sharma","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.08.016_b0550","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1210\/en.2011-0091","article-title":"Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30\/GPER in pancreatic beta-cells","volume":"152","author":"Sharma","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.08.016_b0555","doi-asserted-by":"crossref","unstructured":"Wendler A, Wehling M: Is GPR30 the membrane aldosterone receptor postulated 20 years ago? Hypertension 2011;57:e16; author reply e17.","DOI":"10.1161\/HYPERTENSIONAHA.111.170977"},{"key":"10.1016\/j.steroids.2014.08.016_b0560","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","article-title":"A possible association between primary aldosteronism and a lower beta-cell function","volume":"25","author":"Mosso","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0565","first-page":"755","article-title":"Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?","volume":"8","author":"Shimamoto","year":"1994","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0570","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1463-1326.2012.01559.x","article-title":"Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms","volume":"14","author":"van der Zijl","year":"2012","journal-title":"Diab Obes Metab"},{"key":"10.1016\/j.steroids.2014.08.016_b0575","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1097\/HJH.0b013e32833af380","article-title":"Angiotensin receptor blocker\/diuretic combination preserves insulin responses in obese hypertensives","volume":"28","author":"Sowers","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.steroids.2014.08.016_b0580","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc10-2224","article-title":"Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial","volume":"34","author":"van der Zijl","year":"2011","journal-title":"Diab Care"},{"key":"10.1016\/j.steroids.2014.08.016_b0585","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000248135.97380.76","article-title":"Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism","volume":"48","author":"Luther","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.steroids.2014.08.016_b0590","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00125-008-0972-5","article-title":"Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles","volume":"51","author":"Swaminathan","year":"2008","journal-title":"Diabetologia"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X1400213X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X1400213X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T13:42:07Z","timestamp":1746366127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X1400213X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":118,"alternative-id":["S0039128X1400213X"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.08.016","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of aldosterone on insulin sensitivity and secretion","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}